Expression of vascular endothelial growth factor in bone development and bone tumors

Kuznetsova O.M.1, Kushlinski N.E.2, Berezov T.T.1

1. People's Friendship University, Moscow, Russia
2. Blokhin Cancer Research Center, Russian Academy of Medical Sciences
Section: Review
PubMed Id: 14562681
Year: 2003  Volume: 49  Issue: 4  Pages: 360-373
Vascular endothelial growth factor (VEGF) is a homodimeric heparin-binding protein (34-42 kDa), which induces formation of new blood vessels (angiogenesis). VEGF-mediated capillary invasion is an essential signal that regulates growth plate morphogenesis and triggers cartilage remodeling. Thus, VEGF is essential coordinator of chondrocyte death, chondroclast function, extracellular matrix remodeling, angiogenesis and bone formation in the growth plate. VEGF expression in untreated osteosarcoma is predictive for pulmonary metastasis and poor prognosis. VEGF concentration in the serum of patients with malignant bone tumors (osteosarcoma, Ewing's tumor) increased in comparison with norm and benign tumors. VEGF expression in the serum of patients with osteosarcoma associated with the development of metastasis and without metastasis period. The results of investigation indicate the existence of dependence between VEGF expression and degree of tumor malignancy and metastasis. These results testify probable participation of VEGF in biology of the tumor-transformed tissue.
Download PDF:  

Kuznetsova, O. M., Kushlinski, N. E., Berezov, T. T. (2003). Expression of vascular endothelial growth factor in bone development and bone tumors. Biomeditsinskaya Khimiya, 49(4), 360-373.
 2024 (vol 70)
 2023 (vol 69)
 2022 (vol 68)
 2021 (vol 67)
 2020 (vol 66)
 2019 (vol 65)
 2018 (vol 64)
 2017 (vol 63)
 2016 (vol 62)
 2015 (vol 61)
 2014 (vol 60)
 2013 (vol 59)
 2012 (vol 58)
 2011 (vol 57)
 2010 (vol 56)
 2009 (vol 55)
 2008 (vol 54)
 2007 (vol 53)
 2006 (vol 52)
 2005 (vol 51)
 2004 (vol 50)
 2003 (vol 49)